Literature DB >> 2730416

Anti-laminin antibodies in inner ear diseases: a potential marker for infectious and post-infectious processes.

F R Zanetti1, D Plester, R Klein, Z Bursa-Zanetti, P A Berg.   

Abstract

Natural antibodies against laminin (ALA) have been detected recently in some acute and chronic infectious disorders. In our present study sera of a large number of patients with inner ear disorders of unknown etiology (n = 413) were tested for ALA. Control sera were taken from patients with diseases of known infectious etiology and patients with diseases of unknown etiology in which an infectious etiology was suggested. Patients with classical autoimmune diseases as well as healthy blood donors were also included in this study. The highest frequency of ALA was found in patients with sensorineural hearing loss (SNHL) (68%), whereas the incidence of ALA was comparatively uncommon in patients with Menière's disease (14%). In patients with chronic infectious diseases ALA were detected with almost the same frequency as in patients with SNHL. The elevation of the erythrocyte sedimentation rate and the association of ALA-positive SNHL with other chronic inflammatory disorders suggest that ALA might be stimulated by a persisting infectious process. These findings suggest that certain forms of inner ear disorders might have a chronic infectious etiology.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730416     DOI: 10.1007/bf00457463

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  15 in total

1.  Laminin--a glycoprotein from basement membranes.

Authors:  R Timpl; H Rohde; P G Robey; S I Rennard; J M Foidart; G R Martin
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

2.  Characterization and clinical relevance of a new complement-fixing antibody--anti-M8--in patients with primary biliary cirrhosis.

Authors:  P Weber; J Brenner; E Stechemesser; R Klein; U Weckenmann; G Klöppel; M Kirchhof; V Fintelmann; P A Berg
Journal:  Hepatology       Date:  1986 Jul-Aug       Impact factor: 17.425

3.  Antibodies to laminin in preeclampsia.

Authors:  J M Foidart; J Hunt; C M Lapiere; B Nusgens; C De Rycker; M Bruwier; R Lambotte; A Bernard; P Mahieu
Journal:  Kidney Int       Date:  1986-05       Impact factor: 10.612

4.  Sudden deafness and its several treatments.

Authors:  W H Saunders
Journal:  Laryngoscope       Date:  1972-07       Impact factor: 3.325

5.  Enzyme immunoassay ELISA and EMIT.

Authors:  E Engvall
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  High antibody levels against mouse laminin with specificity for galactosyl-(alpha 1-3)galactose in patients with inner ear diseases.

Authors:  R Klein; R Timpl; F R Zanetti; D Plester; P A Berg
Journal:  Ann Otol Rhinol Laryngol       Date:  1989-07       Impact factor: 1.547

7.  Autoimmune sensorineural hearing loss.

Authors:  B F McCabe
Journal:  Ann Otol Rhinol Laryngol       Date:  1979 Sep-Oct       Impact factor: 1.547

8.  Antibodies to basement membrane collagen and to laminin are present in sera from patients with poststreptococcal glomerulonephritis.

Authors:  N A Kefalides; M T Pegg; N Ohno; T Poon-King; J Zabriskie; H Fillit
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

9.  Antibodies to laminin in Chagas' disease.

Authors:  A Szarfman; V P Terranova; S I Rennard; J M Foidart; M de Fatima Lima; J I Scheinman; G R Martin
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

10.  Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues.

Authors:  U Galili; B A Macher; J Buehler; S B Shohet
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

View more
  1 in total

1.  The presence of laminin in the fetal human inner ear.

Authors:  H Yamashita; D Bagger-Sjöbäck; J Wersäll
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.